Individual decision · SEC · 25 Oct 2005
The Commission grants exemptions from Rules 10a-1, 10b-10, 10b-17, and 14e-5, and the Staff issues no-action positions under Section 11(d)(1) and Rules 11d1-2, 15c1-5, 15c1-6, and Regulation SHO for PowerShares Exchange-Traded Fund Trust regarding the PowerShares Lux Nanotech Fund Shares. These relief measures permit secondary market trading without tick restrictions, allow broker-dealers to mark short sales as "short" rather than "short exempt" under specific conditions, and exempt the Trust from notice requirements for Rule 10b-17 and confirmation details for Rule 10b-10 during creation and redemption transactions. The Staff confirms the Trust is excepted from Regulation M Rules 101 and 102, permitting distribution participants to bid for or purchase Shares and allowing the Fund to redeem Creation Units during continuous offerings. These exemptions are contingent upon the Fund maintaining at least 20 Component Stocks and are subject to modification or revocation if material changes occur in the represented facts.
October 25, 2005
Stuart M. Strauss, Esq. Clifford Chance US LLP 31 West 52nd Street New York, NY 10019
Re:
PowerShares Lux Nanotech Portfolio File No. TP 06-07
Dear Mr. Strauss:
In your letter dated October 25, 2005, 1 as supplemented by conversations with the staff of the Division of Market Regulation ("Staff"), PowerShares Exchange-Traded Fund Trust on behalf of itself, the Lux Nanotech Fund, the AmEx, and any other Market on which the Shares may subsequently trade, and persons or entities engaging in transactions in the Shares, requests exemptive, interpretive, or no-action advice regarding Section 11(d)(1) of the Exchange Act and Rules 10a-1, 10b-10, 10b-17, 11d1-2, 14e-5, 15c1-5 and 15c1-6 thereunder, Rules 101 and 102 of Regulation M, and Rule 200(g) of Regulation SHO under the Exchange Act, in connection with secondary market transactions in the Shares on the AmEx, or any other Market on which the Shares may subsequently trade, and the creation and redemption of Creation Units of the Fund.
The Trust is registered with the Securities and Exchange Commission as an open-end management investment company which was organized as a Massachusetts business trust on June 9, 2000. The Trust currently offers nineteen separate investment series and plans to add additional series. The shares of the nineteen separate investment series currently offered by the Trust and certain shares of the New Funds are listed and traded on the AmEx. The AmEx is expected to rely on Rule 19b-4(e) under the Exchange Act to list and trade the Shares. The Trust expects that the AmEx will grant approval for the Shares to be listed and traded on the AmEx upon the Trust's issuance of the Shares. The Fund will invest in common stocks consisting of the Component Stocks of the Lux Nanotech Index 2 and will issue and redeem Shares only in aggregations of 100,000 Shares. The Fund utilizes a passive investment approach and seeks to track the performance of the Index by investing in a portfolio of stocks that seeks to replicate the Index through the use of quantitative analytical procedures. The investment objective of the Fund is to provide investment results that, before expenses, correspond generally to the total return of the Index, the value of which will be published by the AmEx. 3
Response:
Rule 10a-1
Rule 200 of Regulation SHO defines "short sale" and Rule 10a-1 under the Exchange Act governs short sales generally. Paragraph (a) of Rule 10a-1 covers transactions in any security registered on a national securities exchange, if trades in such security are reported pursuant to an effective transaction reporting plan, and prohibits short sales with respect to these securities unless such sales occur on a "plus tick," (that is, a price above the price at which the immediately preceding sale was effected), or "zero-plus tick," (that is, at the last sale price if it was higher than the last different price). Rule 10a-1 is designed to prevent the market price of a security registered on, or admitted to unlisted trading privileges on, a national securities exchange from being manipulated downward by unrestricted short selling.
On the basis of your representations and the facts presented, in particular the composite and derivative nature of the Shares, it would not appear that trading in the Shares would be susceptible to the practices that Rule 10a-1 is designed to prevent. In particular, the Trust anticipates that the market value of the Shares will rise or fall based on changes in the net asset value of the Component Stocks of the Index and supply and demand. Moreover, the short sale rule does not apply to analogous derivative products such as index options and index futures contracts. Accordingly, the Commission hereby grants an exemption from Rule 10a-1 to permit sales of the Shares without regard to the "tick" requirements of Rule 10a-1.
We note that the exemption from Rule 10a-1 would not apply to secondary market portfolio sales of Component Stocks made in connection with the redemption of the Shares. In addition, this exemption is contingent upon the Funds maintaining at least 20 Component Stocks.
Rule 200(g) of Regulation SHO
Rule 200(g) of Regulation SHO provides that a broker-dealer must mark all sell orders of any equity security as "long," "short," or "short exempt." Rule 200(g)(2) requires that a short sale order must be marked "short exempt" if the seller is relying on an exception from the tick test of Rule 10a-1 of the Exchange Act or any short sale price test of any exchange or national securities association.
Accordingly, in conjunction with the exemption granted above to permit sales of Shares without regard to the "tick" requirements of Rule 10a-1, on the basis of your representations and the facts presented, and without necessarily concurring in your analysis, the Staff will not recommend to the Commission enforcement action under Rule 200(g) of Regulation SHO if a broker-dealer marks "short," rather than "short exempt," a short sale that is effected in the Shares, subject to the following conditions:
For each exempt short sale, the various market centers that execute such sales have instituted procedures to "mask" the short sale character of the transaction so that they are executed as short exempt;
Such market centers monitor on a regular basis to confirm that any such product or transaction continues to meet the conditions for the exemptive relief and re-institute the price test for any product or transaction that fails to satisfy such conditions;
A broker-dealer executing exempt short sales will mark such sales as "short," and in no event will such sales be marked "long;" and
The market centers will maintain an audit trail of all such trade executions, which is capable of being produced and subject to review upon request by the Commission and other appropriate regulatory authorities.
Regulation M
Redeemable securities issued by an open-end management investment company are excepted from the provisions of Rule 101 and 102 of Regulation M. The Commission granted the Trust and its co-applicants exemptions from certain provisions of the 1940 Act with respect to the Powershares Dynamic Market Portfolio and the Powershares Dynamic OTC Portfolio in order to permit the Trust to maintain its registration as an open-end investment company and to issue shares that are redeemable only in Creation Unit size aggregations of Shares.
Rule 101 of Regulation M
Generally, Rule 101 of Regulation M is an anti-manipulation regulation that, subject to certain exemptions, prohibits any "distribution participant" and its "affiliated purchasers" from bidding for, purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of a distribution until after the applicable restricted period except as specifically permitted in the Regulation. 4 The provisions of Rule 101 of Regulation M apply to underwriters, prospective underwriters, brokers, dealers, or other persons who have agreed to participate or are participating in a distribution of securities.
On the basis of your representations and the facts presented, particularly that the Trust is a registered open-end management investment company that will continuously redeem at net asset value Creation Unit size aggregations of the Shares; and the secondary market price of the Shares should not vary substantially from the net asset value of such Shares, which is based on the value of the Component Stocks in the underlying Index and will be computed on a daily basis, the Staff hereby confirms that the Trust is excepted under paragraph (c)(4) of Rule 101 of Regulation M, thus permitting persons who may be deemed to be participating in a distribution of the Shares to bid for or purchase the Shares during their participation in such distribution. 5
The Staff also confirms the interpretation of Rule 101 of Regulation M that a redemption of Creation Unit size aggregations of the Shares and the receipt of Component Stocks in exchange therefor by a participant in a distribution of the Shares would not constitute an "attempt to induce any person to bid for or purchase a covered security, during the applicable restricted period" within the meaning of Regulation M, and therefore would not violate Regulation M.
Rule 102 of Regulation M
Rule 102 of Regulation M prohibits issuers, selling security holders, or any affiliated purchaser of such person from bidding for, purchasing, or attempting to induce any person to bid for or purchase a covered security during the applicable restricted period in connection with a distribution of securities effected by or on behalf of an issuer or selling security holder. Rule 100 of Regulation M defines "distribution" to mean any offering of securities that is distinguished from ordinary trading transactions by the magnitude of the offering and the presence of special selling efforts and selling methods.
On the basis of your representations and the facts presented, particularly that the Trust is a registered open-end management investment company that will redeem at net asset value Creation Units of the Shares, the Staff hereby confirms that the Trust is excepted under paragraph (d)(4) of Rule 102 of Regulation M, thus permitting the Fund to redeem the Shares during the continuous offering of the Shares.
Rule 14e-5
Rule 14e-5 under the Exchange Act, among other things, prohibits a person making a tender offer or exchange offer for any equity security from directly or indirectly, purchasing or arranging to purchase any subject or related securities except as part of the offer, from the time the offer is publicly announced until its expiration.
Rule 14e-5 explicitly includes dealer-managers within the rule's definition of "covered person." Accordingly, while acting as dealer-manager of a tender offer for a Component Stock, a dealer-manager is prohibited from purchasing or arranging to purchase that Component Stock until the expiration of the offer.
On the basis of your representations and the facts presented, particularly that purchases or redemptions of the Shares would not appear to result in the abuses at which Rule 14e-5 is directed, and that any bids or purchases by dealer-managers would not be effected for the purpose of facilitating a tender offer, the Commission hereby grants an exemption from Rule 14e-5 to permit any person acting as dealer-manager of a tender offer for a Component Stock to: (1) redeem the Shares in Creation Unit size aggregations to the Trust for Component Stocks that may include a security subject to the tender offer; and (2) purchase the Shares during such offer. 6
Rule 10b-17
Rule 10b-17, with certain exceptions, requires an issuer of a class of publicly traded securities to give notice of certain specified actions (for example, a dividend distribution, stock split, or rights offering) relating to such class of securities in accordance with Rule 10b-17(b). On the basis of your representations and the facts presented, particularly that the Commission has determined to grant an exemption from the 1940 Act to register the Trust as an open-end management investment company notwithstanding the fact that it issues Shares with limited redeemability, the Commission hereby grants an exemption from the requirements of Rule 10b-17 to the Trust with respect to transactions in the Shares. 7
Rule 10b-10
Rule 10b-10 under the Exchange Act requires a broker-dealer that effects a securities transaction with or for the account of a customer to provide, at or before the completion of the transaction, a written confirmation statement to the customer disclosing the information specified in paragraph (a) of Rule 10b-10. The required information includes the identity, price, and number of shares or units (or principal amount) of the security purchased or sold by the customer.
On the basis of your representations and the facts presented, and particularly the expected institutional nature of the market for Shares in Creation Unit size aggregations and the public availability of information regarding the composition of the Component Stocks to be tendered or received by customers in the Fund's creation and redemption transactions, we find that it is appropriate in the public interest and consistent with the protection of investors to grant, and hereby grant, an exemption from Rule 10b-10 under the Exchange Act in order to permit broker-dealers that create or redeem Shares on behalf of their customers to confirm such creation or redemption transactions without providing a statement of the identity, price, or number of shares of each individual Component Stocks tendered to or delivered by the Trust pursuant to the creation or redemption transaction. This exemption does not apply to purchases and sales of Shares in the secondary market. This exemption is subject to the following conditions:
Confirmation statements of creation and redemption transactions in Shares will contain all of the information specified in paragraph (a) of Rule 10b-10 other than identity, price, and number of shares of each Component Stock of the Deposit Securities or Fund Securities tendered or received by the customer in the transaction.
Any confirmation statement of a creation or redemption transaction in Shares that omits the identity, price, or number of shares of Component Stocks will contain a statement that such omitted information will be provided to the customer upon request; and
All such requests will be fulfilled in a timely manner in accordance with paragraph (c) of Rule 10b-10.
Section 11(d)(1); Rule 11d1-2
On the basis of your representations and the facts presented, the Staff will not recommend enforcement action to the Commission under Section 11(d)(1) of the Exchange Act if broker-dealers treat Shares, for the purposes of Rule 11d1-2 under the Exchange Act, as "securities issued by a registered ... open-end investment company as defined in the Investment Company Act of 1940" and thereby extend or maintain or arrange for the extension or maintenance of credit on Shares that have been owned by the persons to whom credit is provided for more than 30 days, in reliance on the exemption contained in the rule. The exemption provided in Rule 11d1-2 will not be available, however, with respect to any Shares owned for 30 days or less by the person to whom credit is provided.
In addition, on the basis of your representations and the facts presented, the Staff will not recommend enforcement action to the Commission under Section 11(d)(1) of the Exchange Act if broker-dealers that do not create Shares, but engage in transactions in Shares exclusively in the secondary market, extend or maintain or arrange for the extension or maintenance of credit on Shares, in connection with such secondary market transactions. 8
Rule 15c1-5 and 15c1-6
Rule 15c1-5 under the Exchange Act requires a broker-dealer controlled by, controlling, or under common control with the issuer of any security, before entering into any contract with or for a customer for the purchase or sale of such security, to disclose that relationship and to provide written disclosure to the customer of such control relationship at or before the completion of the transaction.
Rule 15c1-6 under the Exchange Act generally requires a broker-dealer that effects a transaction with a customer in any security in a primary or secondary distribution in which the broker-dealer is participating or is otherwise financially interested to provide written notification to the customer of the existence of such participation or interest at or before the completion of each transaction.
In light of the composite nature of the Shares and the relatively small proportionate share of any Component Stock, transactions in Shares do not appear to result in any of the harms that Rules 15c1-5 and 15c1-6 are designed to prevent. Therefore, on the basis of your representations and the facts presented, the Staff will not recommend that the Commission take enforcement action under Rule 15c1-5 if a broker-dealer executes transactions in Shares without disclosing any control relationship with an issuer of a Component Stock. Moreover, on the basis of your representations and the facts presented, the Staff will not recommend that the Commission take enforcement action under Rule 15c1-6 if a broker-dealer executes transactions in Shares without disclosing its participation or interest in a primary or secondary distribution of a Component Stock.
The foregoing exemptions from Rules 10a-1, 10b-10, 10b-17, 14e-5, interpretations of Rules 101 and 102 of Regulation M, and no-action positions taken under Section 11(d)(1) and Rules 11d1-2, 15c1-5, and 15c1-6 and Regulation SHO under the Exchange Act are based solely on your representations and the facts presented to Staff, and are strictly limited to the application of those rules to transactions involving the Shares under the circumstances described above and in your letter. Such transactions should be discontinued, pending presentation of the facts for our consideration, in the event that any material change occurs with respect to any of those facts or representations. Moreover, the foregoing exemptions from Rules 10a-1, 10b-10, 10b-17, and 14e-5, interpretations Rules 101 and 102 of Regulation M and no-action positions taken under Section 11(d)(1) and Rules 11d1-2, 15c1-5, and 15c1-6 and Regulation SHO under the Exchange Act are subject to the condition that such transactions in Shares, any Component Stock, or any related securities are not made for the purpose of creating actual, or apparent, active trading in or raising or otherwise affecting the price of such securities.
These exemptions, interpretations, and no-action positions are subject to modification or revocation if at any time the Commission or Staff determines that such action is necessary or appropriate in furtherance of the purposes of the Exchange Act. In addition, persons relying on these exemptions, interpretations, and no-action positions are directed to the anti-fraud and anti-manipulation provisions of the Exchange Act, particularly Sections 9(a), 10(b), and Rule 10b-5 thereunder. Responsibility for compliance with these and other provisions of the federal or state securities laws must rest with persons relying on these exemptions, interpretations, and no-action positions. The Staff expresses no view with respect to other questions that the proposed transactions may raise, including, but not limited to, the adequacy of disclosure concerning, and the applicability of other federal and state laws to, the proposed transactions.
For the Commission, by the Division of Market Regulation, pursuant to delegated authority,
James A. Brigagliano Assistant Director
Endnotes
1 We have enclosed a photocopy of your letter. Each defined term in this letter has the same meaning as defined in your letter, unless we note otherwise.
2 The Lux Nanotech Index is a trademark of Lux Research, Inc.
3 The value of the Shares will also be published by the AmEx on an ongoing basis.
4 17 CFR 242.101.
5 We note that Regulation M does not prohibit a distribution participant and its affiliated purchasers from bidding for and purchasing Component Stocks in accordance with the exceptions contained in paragraphs (b)(6) and (c)(1) of Rule 101. Rule 101(b)(6)(i) excepts basket transactions in which bids or purchases are made in the ordinary course of business in connection with a basket of 20 or more securities in which a covered security does not comprise more that 5% of the value of the basket purchased. Rule 101(b)(6)(ii) excepts adjustments to such a basket made in the ordinary course of business as a result of a change in the composition of a standardized index. Also, Rule 101(c)(1) excepts transactions in actively-traded securities, that is, securities that have an average daily trading volume value of at least $1 million and are issued by an issuer whose common equity securities have a public float value of at least $150 million; provided however, that such securities are not issued by the distribution participant or an affiliate of the distribution participant.
6 The Staff also confirms its no-action position under Rule 14e-5 when a broker-dealer (including a member or member organization of the AmEx or other national securities exchange), acting as a dealer-manager of a tender offer for a Component Stock, purchases such Component Stock in the secondary market for the purpose of tendering them to purchase a Creation Unit size aggregation of Shares, if such transactions are effected as adjustments to such a basket in the ordinary course of business as a result of a change in the composition of the relevant index.
7 We also note that compliance with Rule 10b-17 would be impractical in light of the nature of the Funds. This is because it is not possible for the Trust to accurately project ten days in advance what dividend, if any, would be paid on a particular record date.
8 In your letter, you represent that the Board of Trustees of the Trust has adopted a services and distribution plan for the Fund pursuant to Rule 12b-1 under the 1940 Act, and that in accordance with this plan, the Fund is authorized to pay up to 0.25% of its average daily net assets each year for certain distribution-related activities. We note in this regard that any broker-dealer (including any natural person associated with such broker-dealer) that receives 12b-1
Incoming Letter:
The Incoming Letter is in Acrobat format.
1
CLl FFORD CLIFFORD CHANCE US LLP
CHANCE 31 WEST 52ND STREET
NEW YORK NY 10019 6131
TEL +1 212 878 8000
FAX +1 212 878 8375 www.cliffordchance.com
Stuart M. Strauss
Lateral Partner
DIRECT TEL +1 212 878 4931
Division of Market Regulation
Securities and Exchange Commission
450 Fifth Street, N.W., Mail Stop 10-1
Washington, DC 20549
Re: Amended and Restated Request for Exemptive, Interpretive or No-Action Relief from Section 1 l(d)(l) of the Securities Exchange Act of 1934 and Rules 10a-1; lob-10; lob-17; 1 ldl-2; 14e-5; 15cl-5; and 15cl-6; Rules 10 1 and 102 of Regulation M and Rule 200(g) of Regulation SHO promulgated under the Securities Exchange Act of 1934. Dear Mr. Brigagliano and Ms. McGuire:
PowerShares Exchange-Traded Fund Trust (the "Trust") is an open-end management investment company which was organized on June 9, 2000 as a Massachusetts business trust. The Trust currently offers nineteen separate investment series.' The Trust plans to add additional series These include the PowerShares Dynamic Market Portfolio, PowerShares Dynamic OTC Portfolio, PowerShares Dynamic Large Cap Growth Portfolio, PowerShares Dynamic Large Cap Value Portfolio, PowerShares Dynamic Mid Cap Growth Portfolio, PowerShares Dynamic Mid Cap Value Portfolio, PowerShares Dynamic Small Cap Growth Portfolio, PowerShares Dynamic Small Cap Value Portfolio, PowerShares Golden Dragon Halter USX China Portfolio, PowerShares High Yield Equity Dividend AchieversTM Portfolio, PowerShares WilderHill Clean Energy Portfolio, PowerShares Dynamic Biotechnology & Genome Portfolio, PowerShares Dynamic Food & Beverage Portfolio, PowerShares Dynamic Leisure and Entertainment Portfolio, PowerShares Dynamic Media Portfolio, PowerShares Dynamic Networking Portfolio, PowerShares Dynamic Pharmaceuticals Portfolio, PowerShares Dynamic Semiconductors Portfolio and PowerShares Dynamic Software Portfolio (the "Current Funds"). The Trust's registration statements on Form N-1A were declared effective by the Securities and Exchange Commission on April 17, 2003 (with respect to the PowerShares Dynamic Market Portfolio and the PowerShares Dynamic OTC Portfolio), on December 9, 2004 (with respect to the PowerShares Golden Dragon Halter USX China Portfolio and the PowerShares High Yield Equity Dividend AchieversTM Portfolio), on March 3, 2005 (with respect to the PowerShares WilderHill Clean Energy Portfolio, PowerShares Dynamic Large Cap Growth Portfolio, PowerShares Dynamic Large Cap Value Portfolio, PowerShares Dynamic Mid Cap Growth Portfolio, PowerShares Dynamic Mid NYA 741984.7
CLIFFORD
CLIFFORD CHANCE US LLP
CHANCE
(the "New ~unds").~ he shares of the nineteen separate investment series currently offered by the Trust are listed and traded on the American Stock Exchange, LLC ("ArnEx"). The ArnEx is expected to rely on Rule 19b-4(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), to list and trade shares of the New Funds. The Trust expects that the ArnEx will grant approval for the shares of the New Funds that are not currently effective to be listed and traded on the AmEx upon the Trust's issuance of such shares. This letter relates to the shares of the PowerShares Lux Nanotech Portfolio (the "Lux Nanotech Fund"), one of the New Funds. The Lux Nanotech Fund is also referred to individually as the "Fund". The shares of the Lux Nanotech Fund are also referred to as "Shares". The Fund will invest in common stocks specifically consisting of the component securities of the Lux Nanotech Index (the "Lux Nanotech Inde~")~ (hereinafter also referred to as the "Index"). The Trust will issue and redeem Shares only in aggregations of 100,000 Shares (referred to as "Creation ~nits").~ The Trust on behalf of itself, the Fund, the AmEx and any other national securities exchange or national securities association on or through which the Shares may subsequently trade (with each such market being a "Market"), and persons or entities engaging in transactions in Shares, as the case may be, requests that the Securities and Exchange Commission (the "Commission") grant exemptive, Cap Value Portfolio, PowerShares Dynamic Small Cap Growth Portfolio and PowerShares Dynamic Small Cap Value Portfolio) and on June 23, 2005 (with respect to the PowerShares Dynamic Biotechnology & Genome Portfolio, PowerShares Dynamic Food & Beverage Portfolio, PowerShares Dynamic Leisure and Entertainment Portfolio, PowerShares Dynamic Media Portfolio, PowerShares Dynamic Networking Portfolio, PowerShares Dynamic Pharmaceuticals Portfolio, PowerShares Dynamic Semiconductors Portfolio and PowerShares Dynamic Software Portfolio) (Securities Act File No. 333-100228, Investment Company Act File No. 81 1-21265). 2 The New Funds of the Trust that are not yet effective but have filed registration statements with the Securities and Exchange Commission include the PowerShares Dynamic Brand Name Products Portfolio, PowerShares Dynamic Consumer Electronics Portfolio, PowerShares Dynamic Hardware Portfolio, PowerShares Dynamic Internet Software & Services Portfolio, PowerShares Dynamic Telecommunications Services Portfolio, PowerShares Dynamic Wireless Portfolio, PowerShares SPADETM Defense Portfolio, PowerShares Value Line #1 TimelinessTM and SafetyTM Portfolio, PowerShares Dividend AchieversTM Portfolio, PowerShares High Growth Rate Dividend AchieversTM Portfolio, PowerShares International Dividend AchieversTM Portfolio, PowerShares Zacks Micro Cap Portfolio, PowerShares Zacks Small Cap Portfolio, PowerShares Dynamic Building & Construction Portfolio, PowerShares Dynamic Energy
Exploration & Production Portfolio, PowerShares Dynamic Insurance Portfolio, PowerShares Lux Nanotech Portfolio, PowerShares Dynamic Oil Services Portfolio, PowerShares Dynamic Retail Portfolio and PowerShares Dynamic Utilities Portfolio. 3 The Lux Nanotech Index is a trademark of Lux Research, Inc. 4 On March 28, 2003, the Commission granted the Trust and its co-applicants exemptions from the provisions of sections 2(a)(32) and 5(a)(l) of the 1940 Act in order to permit the Trust to maintain its registration as an open-end investment company and to issue shares that are redeemable only in Creation Unit size aggregations of Shares with respect to the PowerShares Dynamic Market Portfolio and the PowerShares Dynamic OTC Portfolio. NYA 741984.7
CLI FFmORD CLIFFORD CHANCE US LLP
CHANCE interpretive or no-action relief from Section 1 1 (d)(l ) of the Exchange Act, Rules 10a- 1, lob- 10, 10b17, 1 ldl-2, 14e-5, 15cl-5 and 15cl-6 under the Exchange Act, Rules 101 and 102 of Regulation M and Rule 200(g) of Regulation SHO under the Exchange Act ("Regulation SHO"), in connection with secondary market transactions in Shares and the creation or redemption of Creation Units of Shares, as discussed below. The relief requested in this letter is substantially similar to the relief granted by the Commission in a letter from James A. Brigagliano, Assistant Director, Division of Market Regulation to Stuart M. Strauss, Clifford Chance dated March 2, 2005, with respect to the trading of the PowerShares WilderHill Clean Energy Portfolio. The AmEx has previously received relief (the "AmEx Letter") with respect to those Exchange Act provisions and rules thereunder. Exchange-traded funds ("ETFs") listed and traded on the AmEx may rely upon the relief granted in the AmEx Letter if such ETFs meet certain conditions, including the following: (a) at least 85% of the ETF must be comprised of component stocks that have a minimum average daily trading volume (ADTV) of at least $1 million during each of the previous two (2) months of trading prior to formation of the relevant ETF and (b) at least 85% of the ETF must be comprised of component stocks that have a minimum public float value of at least $150 million; provided, however, if the ETF has 200 or more component stocks, then 75% of the Component Stocks (as defined below) must meet the $1 million ADTV and $1 50 million public float thresholds. The Current Funds and the New Funds other than the Fund meet all relevant conditions of the AmEx Letter, and they accordingly are relying on the AmEx Letter with respect to the aforementioned Exchange Act provisions and rules.6 However, the Lux Nanotech Index currently does not meet the minimum average daily trading volume criteria of the AmEx Letter set forth above, and therefore the Trust requests relief with respect to the Fund from the aforementioned Exchange Act provisions and rules.7 The Trust notes that its proposal-the creation and issuance by an investment company of shares that individually trade on the AmEx or another Market, but that in large aggregations can be purchased from and redeemed with the issuing investment company-is no longer novel. The Commission has in the past thirteen years considered and approved many proposals similar to this proposal. Some of these products have been trading publicly for years, and the Trust is not aware of 5 Letter from James A. Brigagliano, Assistant Director, Division of Market Regulation, to Claire P. McGrath, Vice President and Special Counsel, AmEx, dated August 17, 200 1. 6 The PowerShares WilderHill Clean Energy Portfolio did not meet the two criteria of the AmEx Letter discussed above and was granted relief by the Commission on March 2, 2005 substantively similar to the relief requested by this
letter. 7 Except for the minimum average daily trading volume criteria of the AmEx Letter set forth above, the Lux Nanotech Index meets all conditions of the AmEx Letter, including the minimum public float requirements. NYA 741984.7
CLI FFORD CLIFFORD CHANCE US LLP
CHANCE any abuses associated with them. Indeed, several of the products have been so embraced by investors that they routinely are among the highest volume securities on the exchanges on which they trade.* The Fund. The Fund is a separate investment portfolio of the Trust. The investment objective of the Fund is to provide investment results that, before expenses, correspond generally to the total return of the Lux Nanotech Index, the value of which will be published by the ~rn~x.~ The Fund's investment objective is a fundamental policy and cannot be changed unless a majority of shareholders approve the change. 8 The SEC has previously granted exemptive or no-action relief under Rules 10a-1; lob-6; lob-7; 10b10; lob- 13; lob- 17; 1 1 dl -2; 15c 1-5; 15c 1-6 and Regulation M under the Exchange Act similar to that requested here. See e.g., Letter from Nancy Sanow, Assistant Director, Division of Market Regulation to James Duffy, Senior Vice President and General Counsel, AMEX, dated January 22, 1993 with respect to trading of SPDR Trust, Series 1; Letter from Nancy Sanow, Assistant Director, Division of Market Regulation to James Duffy, Senior Vice President and General Counsel, AMEX, dated April 21, 1995 with respect to trading of MidCap SPDR Trust; Letters from Larry E. Bergman, Senior Associate Director, Division of Market Regulation to Stuart M. Strauss, Gordon Altman Butowsky, dated December 14, 1998 and December 22, 1998, respecting the trading of the Select Sector SPDR Trust; Letter from James Brigagliano, Assistant Director, Division of Market Regulation to James Duffy, Senior Vice President and General Counsel, AMEX, dated March 3, 1999 with respect to the trading of the Nasdaq 100 Trust; Letter from James Brigagliano, Assistant Director, Division of Market Regulation to Kathleen Moriarty, Carter, Ledyard & Milburn dated May 16, 2000 with respect to the trading of the ishares Trust; Letter from James Brigagliano, Assistant Director, Division of Market Regulation, to Stuart Strauss, Mayer, Brown & Platt dated September 26, 2000 with respect to the trading of the streetTRACKS@ Series Trust; Letter from James Brigagliano, Assistant Director, Division of Market Regulation to W. John McGuire, Morgan, Lewis & Bockius LLP dated July 25, 2002 with respect to the trading of various series funds of the ishares Trust; Letter from James Brigagliano, Assistant Director, Division of Market Regulation, to Stuart Strauss, Mayer, Brown Rowe & Maw dated October 21, 2002 with respect to the trading of the ~resco~~ Index Shares Fund; Letter from James Brigagliano, Assistant Director, Division of Market Regulation to Jack P. Drogin, Morgan, Lewis & Bockius LLP dated September 25, 2003 with respect to the trading of the ishares Lehman U.S. Treasury Inflation Protected Securities Fund and the ishares Lehman U.S. Aggregate Bond Fund (each a series of the ishares Trust); Letter from James A. Brigagliano, Assistant Director, Division of Market Regulation to Stuart
Strauss, Clifford Chance dated March 2, 2005 with respect to the trading of the Powershares WilderHill Clean Energy Portfolio. 9 The value of the Shares will also be published by the ArnEx on an ongoing basis like other publicly traded shares. For additional information, see Application Orders (No. 8 12- 129 1 1) pursuant to Section 6(c) of the 1940 Act as granted on March 28, 2003 (the "Application"). In addition, see the registration statement for the Trust, File No. 81 1-21265 (the "Registration Statement"). A11 statements contained herein relating to the Trust are qualified in their entirety by the Application and the Registration Statement. The Trust has also sought exemptive relief to permit certain New Funds other than the Fund to offer their shares in a subscription offering with an initial sales charge. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
The Fund intends to maintain the required level of diversification and otherwise conduct its operations so as to qualify as a "regulated investment company" for purposes of the Internal Revenue Code. The Index. Lux Nanotech Index. The Lux Nanotech Index is designed to measure the performance of securities issued by companies in the nanotechnology field, which are publicly traded in the United States. Stocks are selected based on expert evaluation by the Lux Nanotech Index Selection Committee (the "Selection Committee"). The list of component stocks is reviewed quarterly, at the discretion of the Selection Committee. The Lux Nanotech Index currently consists of 26 component stocks ("Component Stocks"). Companies selected for the Lux Nanotech Index include those that are involved with funding nanotechnology development, developing nanotechnology applications, manufacturing goods that incorporate those applications andlor supplying tools and instrumentation to nanotechnology researchers. In addition, the Lux Nanotech Index also aims to track performance across three broad industry sectors impacted by nanotechnology, including materials and manufacturing, electronics and IT and healthcare and life sciences. The relative pace at which companies in these sectors are incorporating emerging nanotechnology is reflected in the Lux Nanotech Index composition. The Lux Nanotech Index uses modified equal dollar weighting. Currently no single stock exceeds 5% of the total Lux Nanotech Index weight. In conjunction with the scheduled quarterly updates to the Lux Nanotech Index, the components are split into two groups: nanotechnology specialists and end-use incumbents. Components within each group are equally weighted as described below:
(1) Nanotechnology specialists are defined as small- and mid-sized companies (less than $5 billion in annual revenue) that focus specifically on developing or funding emerging nanotechnology applications. All have nanotechnology as either a company-wide or businessunit-wide focus, and most work with larger companies as manufacturing or distribution partners. End-use incumbents are large companies (greater than $5 billion in annual revenue) that are applying nanotechnology to existing product lines. All are leaders in nanotechnology research and development, commercialization in products, or both. (2) The two groups are then equally weighted with seventy-five percent (75%) applied to the nanotechnology specialist components and twenty-five percent (25%) for the end-use incumbent components. To be included in the Lux Nanotech Index, components must meet the following on the determination date:
NYA 741984.7
CLI FFORD CLIFFORD CHANCE US LLP
CHANCE
(1) Be listed on the NYSE or AMEX, or quoted on the NASDAQ National Markets or Small Cap Market systems. (2) Have a minimum $75 million market valuation. (3) Have a minimum average daily trading volume over the preceding three months of 50,000 shares. The Selection Committee may at any time and from time to time change the number of companies comprising the Lux Nanotech Index by adding or deleting one or more components, or replace one or more issues contained in the Lux Nanotech Index with one or more substitute stocks of its choice if, in the Index Provider's discretion, such addition, deletion or substitution is necessary or appropriate to maintain the quality and/or character of the industry groups to which the Lux Nanotech Index relates. Changes to the composition and/or the Component Stock weights in the Lux Nanotech Index typically take effect at the scheduled quarterly rebalancing of the Index. In no event will there be less than 20 Component Stocks that comprise the Lux Nanotech Index. Please see Appendix A for additional information regarding the Lux Nanotech Index. Method of Purchase. ALPS Distributors, Inc. (the "Distributor") acts on an agency basis and is the Fund's "principal underwriter" as defined in Section 2(a)(29) of the Investment Company Act of 1940, as amended ("1940 Act"). Shares are issued and sold by the Fund only in Creation Units on a continuous basis through the Distributor at their net asset value next determined after receipt of an order in proper form. The Creation Unit of the Fund consists of 100,000 Shares. Creation Units of Shares may be purchased only by or through a DTC Participant that has entered into an agreement with the Trust, the Distributor and the transfer agent, with respect to creations and redemptions of Creation Units ("Authorized Participant"). The Distributor will deliver the Trust's Prospectus (and, upon request, the Fund's Statement of Additional Information) to each person purchasing Creation Units. The consideration for purchase of a Creation Unit generally consists of the deposit of a designated portfolio of equity securities constituting a substantial replication, or representation, of the Fund's benchmark Index (the "Deposit Securities") and an amount of cash computed as described below (the "Balancing Amount"). Together, the Deposit Securities and the Balancing Amount constitute the "Portfolio Deposit," which represents the minimum investment amount for the purchase of Shares from the Trust. The Balancing Amount represents the difference between the net asset value of a Creation Unit and the market value of the Deposit Securities. Creation Units of the Fund may be created in advance of receipt by the Trust of all or a portion of the applicable Deposit Securities as described below. In these circumstances, the initial deposit will have a value greater than the net asset value of the Shares on the date the order is placed in proper form since in addition to available Deposit Securities,
cash must be deposited in an amount equal to the sum of (i) the Cash Component, plus (ii) 115% of the market value of the undelivered NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
Deposit Securities (the "Additional Cash Deposit"). An additional amount of cash shall be required to be deposited with the Trust, pending delivery of the missing Deposit Securities to the extent necessary to maintain the Additional Cash Deposit with the Trust in an amount at least equal to 115% of the daily marked to market value of the missing Deposit Securities. The Participant Agreement will permit the Trust to buy the missing Deposit Securities at any time. Authorized Participants will be liable to the Trust for the costs incurred by the Trust in connection with any such purchases. These costs will be deemed to include the amount by which the actual purchase price of the Deposit Securities exceeds the market value of such Deposit Securities on the day the purchase order was deemed received by the Distributor plus the brokerage and related transaction costs associated with such purchases. The Trust will return any unused portion of the Additional Cash Deposit once all of the missing Deposit Securities have been properly received by the custodian or purchased by the Trust and deposited into the Trust. In addition, a transaction fee of $500 will be charged in all cases, plus an additional fee of up to four times the transaction fee may be charged in certain cases as described below. All transaction fees and additional fees will be fdly disclosed in the Trust's Prospectus or the Fund's Statement of Additional Information. All standard orders to purchase Creation Units must be received by the Distributor no later than the closing time of the regular trading session on the ArnEx, ordinarily 4:00 p.m., New York time ("Closing Time") on the date such order is placed in order for the purchase of Creation Units to be effected based on the net asset value of Shares as next determined on such date after receipt of the order in proper form. In the case of Custom Orders (as described below), the Distributor must receive the order no later than 3:00 p.m. New York time. Any order that is not in proper form will be rejected. After the Fund has accepted a purchase order and received delivery of the Deposit Securities and any accompanying cash payment, the Depositary Trust Company will instruct it to initiate "delivery" of the appropriate number of Shares to the book-entry account specified by the Authorized Participant. The delivery of Creation Units of the Fund so created will occur no later than the third Business Day following the day on which the purchase order is deemed received by the Distributor. The Trust reserves the right to offer a "cash" option for sales and redemptions of Shares (subject to applicable legal requirements), although it has no current intention of doing so. As described above, Shares may be issued in advance of receipt of Deposit Securities subject to various conditions including a requirement to maintain on deposit with the Trust cash at least equal to 115% of the market value of the missing Deposit Securities. The Fund may allow
an in-kind purchaser to substitute cash, or the Fund may substitute cash in the case of a redemption, in lieu of such purchaser or redeemer depositing or receiving one or more of the requisite Deposit Securities. In each instance of such cash sales or redemptions, the Trust may impose transaction fees that will be higher than the transaction fees associated with in-kind purchases or redemptions. In all cases, such fees will be limited in accordance with the requirements of the Commission applicable to management investment companies offering redeemable securities, and will be fully disclosed in the Fund's Prospectus or the Trust's Statement of Additional Information. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE!
The Adviser (as defined below) makes available through the National Securities Clearing Corporation ("NSCC") on each Business Day, immediately prior to the opening of business on the ArnEx (currently 9:30 a.m., New York time), the list of the names and the required number of such shares of each Deposit Security to be included in the current Portfolio Deposit (based on information at the end of the previous Business Day) for the Fund. Such Portfolio Deposit is applicable, subject to any adjustments as described below, to effect creations of Creation Units of the Fund until such time as the next-announced composition of the Deposit Securities is made available. The identity and number of shares constituting the Deposit Securities required for a Portfolio Deposit for the Fund changes as rebalancing adjustments and corporate action events are reflected from time to time by Powershares Capital Management LLC, as the adviser to the Fund (the "Adviser"), with a view to remain consistent with the investment objective of the Fund. The composition of the Deposit Securities may also change in response to adjustments to the weighting or composition of the securities constituting the Index. In addition, the Trust reserves the right to permit or require the substitution of an amount of cash (i.e., a "cash in lieu" amount) to be added to the Balancing Amount to replace any Deposit Securities which may not be available in sufficient quantity for delivery or which may not be eligible for transfer through the DTC or which may not be eligible for trading by an Authorized Participant or the investor for which the Authorized Participant is acting (described in the Statement of Additional Information) ("Custom Order"). The estimated value of a Creation Unit of Shares as of July 1, 2005 was $1.5 million (assuming the inclusion of all stocks in the Index in their exact weighting). Due to the value of a Creation Unit in the Fund, it is expected that, generally, only institutions will purchase Creation Units from the Fund. Distributor. The Distributor will not distribute Shares in less than Creation Units, and it will not maintain a secondary market in the Shares. The Distributor may enter into selected dealer agreements with other broker-dealers or other qualified financial institutions for the sale of Creation Units of Shares ("Soliciting Dealers"). Such Soliciting Dealers may also be a participant in DTC. The Board of Trustees of the Trust has adopted a services and distribution plan pursuant to Rule 12b-1 under the 1940 Act for the Fund. In accordance with its Rule 12b-1 plan, the Fund is authorized to pay up to 0.25% of its average daily net assets each year for certain distribution-related activities. No 12b-1 fees are currently paid by the Fund and there are no plans to impose these fees. Redemption of Shares. Creation Units of the Fund are redeemable only in Creation Unit Share aggregations through The Bank of New York, in its capacity as the Fund's transfer agent
("Transfer Agent"). Orders to redeem Creation Units of the Fund may only be effected by or through an Authorized Participant. Consistent with Section 22(e) of the 1940 Act and Rule 22e-2 thereunder, the right to redeem Shares directly from the Fund will not be suspended, nor payment upon redemption delayed, except (i) for any period during which the NYSE is closed (other than customary weekend and holiday NYA 741984.7
CLIFFORD CHANCE US LLP
CHANCE closings); (ii) for any period during which trading on the NYSE is suspended or restricted; (iii) for any period during which an emergency exists as a result of which disposal of the Shares or determination of the Shares' net asset value is not reasonably practicable; or (iv) in such other circumstance as is permitted by the Commission. Subject to the foregoing, Creation Unit size aggregations of Shares are redeemable on any Business Day, principally in exchange for Fund Securities (as described below). The Custodian, through the NSCC, makes available immediately prior to the opening of business on the AmEx (currently 9:30 a.m., New York time) on each day that the AmEx is open for business the list of names and the number of shares of the Fund's portfolio securities that will be applicable (subject to possible amendment or correction) to redemption requests received in proper form (as defined below) on that day ("Fund Securities"). Unless cash redemptions are available or specified for the Fund, the redemption proceeds for a Creation Unit generally consist of Fund Securities as announced by the Custodian on the Business Day of the request for redemption, plus cash in an amount equal to the difference between the net asset value of the Shares being redeemed, as next determined after a receipt of a request in proper form, and the value of the Fund Securities, less the redemption transaction fee. In the event that the Fund Securities have a value greater than the net asset value of the Shares, a compensating cash payment to the Trust equal to the differential will be required to be arranged for, by or on behalf of the redeeming investor, by the Authorized Participant. An Authorized Participant or an investor for which it is acting subject to a legal restriction with respect to a particular stock included in the Fund Securities applicable to the redemption of a Creation Unit may be paid an equivalent amount of cash. If redemptions are effected in cash the redemption proceeds will be equal to the net asset value of the Fund's Shares based on the net asset value of the Fund next determined after the redemption request is received in proper form by the Transfer Agent, minus a redemption transaction fee specified for cash redemptions in the Trust's Prospectus (such fee would be equal to the fee for inkind redemptions plus an additional fee because of the extra costs incurred by the Fund in connection with a cash redemption). As with purchases, redemptions of Shares will be effected through NSCC and DTC. In addition, settlement will occur no later than the third business day following the day on which a redemption order is deemed received. Depository Trust Corporation. DTC serves as securities depository for the Shares. (The Shares may be held only in book-entry form; stock certificates will not be issued.) DTC, or its nominee, is the record or registered owner of all outstanding Shares. Beneficial ownership of Shares will be shown on the records
of DTC or its participants (i.e., securities brokers and dealers, banks, trust companies, clearing corporations and certain other organizations, some of whom (and/or their representatives) own DTC. Beneficial owners of Shares are not entitled to have Shares registered in their names, and will not receive or be entitled to receive physical delivery of certificates. NYA 741984.7
CLIFFORD CHANCE US LLP
Accordingly, to exercise any rights of a holder of Shares, each beneficial owner must rely on the procedures of (i) DTC; (ii) DTC Participants; and (iii) brokers, dealers, banks and trust companies that clear through or maintain a custodial relationship with a DTC Participant, either directly or indirectly, through which such beneficial owner holds its interests. Management of the Fund. The Trust's Board of Trustees has responsibility for the overall management of the Fund. The Adviser, subject to the supervision of the Board of Trustees of the Trust, is responsible for the investment management of the Fund. As described in the Fund's Prospectus, the Fund is not managed according to traditional methods of "active" investment management, which involve the buying and selling of securities based upon economic, financial and market analysis and investment judgment. Instead, the Fund, utilizing a "passive" or indexing investment approach, attempts to approximate the investment performance of its benchmark Index by investing in a portfolio of stocks that seeks to replicate the Index through the use of quantitative analytical procedures. The Fund, which has the policy to remain as fully invested as practicable in a pool of equity securities, normally invests at least 90% of its total assets in Component Stocks that comprise the Index. The Fund may invest its remaining assets in money market instruments or funds which reinvest exclusively in money market instruments (subject to applicable limitations under the 1940 Act), in repurchase agreements, in stocks that are in the relevant market but not the Index, in convertible securities, structured notes, exchange traded stock index futures, exchange traded options on futures, stock or stock indexes, as well as options on the Shares. The Adviser anticipates that, generally, the Fund will hold all of the securities which comprise its Index. There may, however, be instances where a stock in the Index is not held or is not held in the same weighting as in the Index. In certain instances, the Adviser may choose to overweight another stock in the Index, purchase securities not included within the Index that the Adviser believes appropriate to substitute for the Index securities or utilize various combinations of other available investment techniques in seeking to track accurately the Index. To the extent that the Fund does not invest in every Component Stock of the Index in the proportions dictated by the Index, it may not track the Index with the same degree of accuracy as a vehicle which does. The Adviser expects that, over time, the "tracking error" of the Fund relative to the performance of the Index (adjusted for the effect of Fund expenses) will be less than 5%. The Trading Market. The Shares will be listed and traded on the AmEx. Shares will be freely tradeable on the ArnEx throughout the trading session. The price of Shares trading on the ArnEx will be based on a current bid/offer market. The trading
market on the ArnEx affords investors the opportunity to assume and liquidate positions in Shares at their discretion, permitting them to take advantage of prices at any time of the trading day. This combination of intra-day liquidity with the Creation Unit purchase and redemption features creates potential arbitrage opportunities that, in turn, should mitigate pricing inefficiencies. This has also been historically the case, the Trust understands, with the Portfolio Depositary Receipts issued by the SPDR Trust, Series 1, the MidCap SPDR Trust, Series I and the DIAMONDS Trust, Series I, Select Sector SPDR Trust, Nasdaq 100 Trust, streetTRACKS03 Series Trust, ishares Trust and ~resco~~ Index Shares Fund. The high degree of NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE historical and expected correlation of net asset value and share prices contrasts with the case of shares of closed-end equity funds which, not having the redemption feature, typically trade at a material discount (and occasionally at a premium) to their underlying net asset values. The structural characteristics of the Shares are believed to provide investors with a liquid, price-efficient security that closely tracks the Index. By offering investors the ability to buy, in effect, a very small amount of a portfolio of equity securities of companies comprising a particular securities index, the Fund allows index-based investing without a major investment of capital or the restrictions of an index-based, non-exchange traded, open-end fund. As noted above, the Shares are designed to provide investors with a highly liquid, price-efficient security that will closely track the underlying Index. Comparison of the Fund to Other Funds Which Have Sought Similar Commission Action. As mentioned above (see, supra, footnote 8), the Commission has granted relief similar to the relief requested herein, except for the relief requested herein with respect to Rule 200(g) of Regulation SHO, to: (i) ishares Trust, (ii) Select Sector SPDR Trust, (iii) the SPDR Trust, the MIDCAP SPDR Trust and the DIAMONDS Trust (referred to collectively as the "PDR Trusts"), (iv) Nasdaq 100 Trust; (v) streetTRACKS Series@ and (vi) ~resco~~ Index Shares Fund which is substantially similar to that requested for the rust." The Commission has recently granted identical relief to that requested herein with regard to Rule 200(g) of Regulation SHO to another portfolio of the Trust, the PowerShares WilderHill Clean Energy Portfolio, and to Vanguard International Equity Index ~unds." The Trust, the ishares Trust, Select Sector SPDR Trust, the PDR Trusts, Nasdaq 100 Trust, streetTRACKSQ Series Trust, ~resco~~ Index Shares Fund, the PowerShares WilderHill Clean Energy Portfolio and the Vanguard International Equity Index Funds share a number of fundamental features. All represent open-end registered investment companies with exchange listed and traded shares. All attempt to track the performance of specified indices which are compiled by experienced index compilers and attempt to remain as fully invested as possible in the securities necessary to correspond to the specified index. All are characterized by issuing shares only in large Creation Unit size aggregations and principally on the basis of a deposit of securities reflecting the composition of the specified index and redeeming shares only in such Creation Unit size aggregations and principally on the basis of a delivery of securities reflecting the composition of the specified index. Although they each have different investment objectives and, as a result, may not necessarily be purchased by the same investors, the products are similarly structured with the view to attracting the same types of 10 Select Sector SPDRs(R), "SPDRsM(R)
and "MIDCAP SPDRsU(R), are trademarks of The McGraw-Hill Companies, Inc. DIAMONDS (SM), is a service mark of Dow Jones & Company, Inc. "WEBS" (SM) is a service mark of Morgan Stanley Dean Witter & Co. ~resco~~ is a service mark of UBS AG. 11 See, Letter from James A. Brigagliano, Assistant Director, Division of Market Regulation to Kathleen Moriarty, Carter, Ledyard & Milburn dated March 9, 2005 with respect to the trading of the VIPER shares of the Vanguard International Equity Index Funds. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE investors, viz., large institutions, in respect of the Creation Unit size aggregations of securities purchasable from and redeemable through the investment company, and retail and institutional investors in respect of the exchange-traded individual securities. The PDR Trusts and the Nasdaq 100 Trust are unit investment trusts which invest in securities in accordance with the terms of their trust instrument. The ishares Trust, Select Sector SPDR Trust, streetTRACKS@ Series Trust, FrescoSM Index Shares Fund and the Trust are management investment companies investing in securities based upon the investment decisions of the Adviser made in conformity with such fund's stated investment objective and investment policies. The PDR Trusts and the Nasdaq 100 Trust invest on the basis of "full replication" of their respective indices: the SPDR Trust invests in all 500 stocks contained in the S&P 500 index, the MIDCAP SPDR Trust invests in all 400 stocks contained in the S&P MidCap 400 index, the Nasdaq 100 Trust invests in all 100 stocks contained in the Nasdaq 100 index and the DIAMOND Trust invests in all 30 stocks contained in the Dow Jones Industrial Average. Each Select Sector SPDR, streetTRACKS Series@, the ~resco~~ Index Shares Fund and the PowerShares WilderHill Clean Energy Portfolio generally invests on the basis of full replication of its respective index. There may, however, be instances in which a component security in the applicable index is not held by such fund or is not held in the same weighting as in the relevant index. In certain instances, the adviser of such fund may choose to overweight another stock in the index, purchase securities not included within the index that the adviser believes are appropriate to substitute for the index securities or utilize various combinations of options, futures andlor structured notes or other investment techniques in seelung to track accurately the benchmark index. The ishares Trust consists of certain portfolios which invest on the basis of full replication and other portfolios which utilize portfolio sampling techniques. As noted above, the Fund will, similar to each Select Sector SPDR, streetTRACKS Series@, the ~resco~~ Index Shares Fund and the PowerShares WilderHill Clean Energy Portfolio generally invest on the basis of full replication of the Index. Rule 10a-1 Rule l0a-l(a)(l)(i) provides that a short sale of an exchange traded security may not be effected below the last regular-way sale price, or at such price unless such price is above the next preceding price at which a sale was reported. The Trust believes that relief from the application of Rule 10a-1 to secondary market transactions in Shares is appropriate insofar as Shares are derivative securities based on a stock index. Application of Rule 10a-1 to Share transactions would not further the Rule's purposes, and exempting such transactions from the Rule would not be inconsistent with such Rule. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
A primary purpose of Rule 10a-1 is to prevent the market price of a stock from being manipulated downward by unrestricted short selling. The market prices of Shares will fluctuate in accordance with changes in net asset value and supply and demand on the ArnEx. Price differences may be due, in large part, to the fact that supply and demand forces at work in the secondary trading market for Shares will be closely related to, but not identical to, the same forces influencing the prices of the component securities of the Index trading individually or in the aggregate at any point in time. Any temporary disparities in market value between Shares and the relevant component securities would tend to be corrected immediately by arbitrage activity. Moreover, Shares in Creation Unit aggregations or multiples thereof may be redeemed through the Trust on any Business Day principally for a distribution of shares of Fund Securities. Under these circumstances, it would appear to be economically futile for short sales in Shares to be utilized to depress Share prices. Moreover, it would similarly be economically futile for short sales in Shares to be utilized to depress particular stocks in the Index. The Index is large enough that it would be economically futile to attempt to use short sales to depress particular index stocks. Currently, no single stock comprises more than 5% of the Lux Nanotech Index. Therefore, a short seller with manipulative intent must spend at least $20 for every $1 of market impact. The economic impracticality of such a strategy is apparent. The trading market for Shares would be adversely affected if Rule 10a-1 operated to prevent dealers or exchange specialists from making short sales of Shares to satisfy customer demand in the absence of an uptick. Requiring an investor to utilize another means to achieve such investor's investment goals would be detrimental to the market for Shares and contrary to the public interest in liquid, efficient securities markets. The Trust notes that it is not requesting relief from Rule 10a-1 for secondary market portfolio sales which may be made in connection with redemptions of Shares. The short sale rule will apply (or not apply) to such transactions as to any other portfolio trade. For the reasons set forth above, the Trust requests that the Commission grant an exemption from Rule 10a-1 to permit sales of the Shares without regard to the "tick" requirements of Rule 10a-1. Rule 200(g) of Regulation SHO Rule 200(g) of Regulation SHO provides that a broker-dealer must mark all sell orders of any equity security as "long," "short," or "short exempt." Rule 200(g)(2) requires that a short sale order must be marked "short exempt" if the seller is relying on an exception from the tick test of Rule 10a-1 of the Exchange Act or any short sale price test of any exchange or national securities association. Under Regulation SHO, as of January 3, 2005, broker-dealers ordinarily would be required to mark "short
exempt" all short sales effected in any class of products, or during certain specified periods of time, that have been granted an exemption from a price test, such as that requested by the Trust in NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
October 25, 2005 connection with the Shares. The Securities Industry Association recently received no-action relief" in this regard (the letter granting such relief being the "SIA Letter"), allowing broker-dealers to mark such short sales as "short" rather than "short exempt" under certain circumstances. If the Commission grants the requested relief with respect to Rule 10a-1, the Trust hereby requests that the relief granted in the SIA Letter be extended to cover transactions in the Shares. The requested relief is subject to the following conditions:
I. For each exempt short sale, the various market centers that execute such sales have
instituted procedures to "mask" the short sale character of the transaction so that they are executed as short exempt;
ii. Such market centers monitor on a regular basis to confirm that any such product or
transaction continues to meet the conditions for the exemptive relief and re-institute the price test for any product or transaction that fails to satisfy such conditions; ...
111. A broker-dealer executing exempt short sales will mark such sales as "short," and in
no event will such sales be marked "long;" and
iv. The market centers will maintain an audit trail of all such trade executions, which is
capable of being produced and subject to review upon request by the Securities and Exchange Commission and other appropriate regulatory authorities. Rule 101 of Regulation M Subject to certain enumerated exceptions, Rule 101 of Regulation M prohibits a "distribution participant", in connection with a distribution of securities, fiom bidding for or purchasing or from attempting to induce any person to bid for or purchase, a "covered security" during the applicable restricted period. "Distribution participant" is defined in Rule 100(b) to include an underwriter or prospective underwriter in a particular distribution of securities, or any broker, dealer or other person who has agreed to participate or is participating in such distribution. We note that Rule 100(b) of Regulation M defines "distribution" for purposes of such Rule as an offering of securities, whether or not subject to registration under the Securities Act of 1933, as amended, that is distinguished fiom ordinary trading transactions by the magnitude of the offering and the presence of special selling efforts and selling methods. We understand that while broker-dealers that tender Deposit Securities to the Trust through the Distributor in return for Creation Unit(s) of Shares generally will not be part of a syndicate or selling group, and no broker-dealer will receive fees, commissions or other remuneration from the Letter from James A. Brigagliano, Assistant Director, Division of Market Regulation, to Ira Hammerman, Senior Vice President and General Counsel, Securities Industry Association, dated January 3,2005. NYA 741984.7 12
CLI FFORD CLIFFORD CHANCE US LLP
CHANCE
Trust or the Distributor for the sale of Creation Units, under certain circumstances they could be deemed to be an "underwriter" or "distribution participant" as those terms are defined in Rule 100(b). The Trust respectfully requests that the Commission or Staff grant exemptive, interpretive or no-action relief fiom Rule 101, as discussed below, to permit persons participating in a distribution of Shares to bid for or purchase, or engage in other secondary market transactions in, such Shares during their participation in such distribution. Paragraph (c)(4) of Rule 101 exempts from its application, inter alia, redeemable securities issued by an open-end management investment company (as such terms are used in the 1940 Act). The Trust is registered as an open-end management investment company under the 1940 Act. However, the individual Shares are not redeemable except in Creation Unit size aggregations. Due to the redeemability of the Shares in Creation Unit size aggregations, there should be little disparity between the Shares' market price and their net asset value per Share. Accordingly, the rationale for exempting redeemable securities of open-end management investment companies from the application of Rule 101 is equally applicable to the Shares. Although redemption is subject to the minimum condition of tendering 100,000 Shares, the Trust is intended to function like any other open-end fund continuously offering its shares. It is in recognition of the special nature of such offerings that openend management investment company and unit investment company securities are exempted under paragraph (c)(4). Without such an exemption, they could not operate as intended. In view of the foregoing, the Trust requests that the Staff confirm that as a result of registration of the Trust as an open-end management investment company and the redeemable nature of the Shares in Creation Unit Size aggregations, transactions in the Shares would be exempted from Rule 101 on the basis of the exception contained in (c)(4) of such Rule. The purpose of Rule 101 is to prevent persons from conditioning the market to facilitate a distribution. Creation Unit size aggregations of Shares may be created, and Shares in Creation Unit size aggregations may be redeemed in kind at net asset value, on any Business Day. Holders of Shares also have the benefit of intra-day secondary market liquidity by virtue of the ArnEx listing. Thus, the secondary market price of Shares should not vary substantially from the net asset value of Shares of the relevant Fund. Because of the redeemability of Shares in Creation Unit size aggregations, coupled with the open-ended nature of the Fund, any significant disparity between the market price of the Shares and net asset value should be eliminated by arbitrage activity. Because their net asset value is largely determined based on the market value of the portfolio securities, neither the creation nor redemption of Shares, nor purchases or sales
of Shares in the secondary market, will impact the net asset value, and such transactions should not have a significant impact on the market value of Shares. The Trust also respectfully requests relief from the provisions of Rule 101 to the extent necessary to permit persons or entities that may be deemed to be participating in the distribution of the Shares or a portfolio security of the Fund to tender Shares for redemption in Creation Unit size aggregations and to receive as part of redemption proceeds the Fund Securities of the Fund. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
The Trust requests, in this regard, that the Staff confirm that the tender of the Shares to the Trust for redemption and the receipt of Fund Securities upon redemption does not constitute a bid for or purchase of any of such securities for the purposes of Rule 101, or alternatively, that the Commission or Staff grant exemptive or no-action relief to the extent necessary to permit redemptions of Shares for Fund Securities as described above. Redemption entails no separate bid for any of the Fund Securities. Absent unusual circumstances, the Trust will not purchase Fund Securities in the secondary market to fulfill a redemption request. Therefore, redemptions of Shares cannot be expected to affect the market price of the Fund Securities. The Trust believes that the purchase of Fund Securities, while engaged in a distribution with respect to such stock, for the purpose of acquiring a Creation Unit Aggregation of Shares should not be exempted from Rule 101. The purpose of Rule 101 is to prevent persons from conditioning the market to facilitate a distribution. Application of Rule 10 1 in this context would not further the anti-manipulative purposes underlying the Rule. In view of the lack of any special financial incentive to create Creation Unit Aggregations of the Shares, combined with a predictable lack of any meaningful potential for the issuance and the secondary market trading of the Shares to affect significantly Share pricing, application of Rule 101 to a broker-dealer or other person who may be participating in a distribution or broker-dealers or other persons in their creation and redemption activities, in their day-to-day ordinary business of buying and selling securities and the Shares, may undermine the potential beneficial market effect of Share trading. Rule 102 of Regulation M The Trust also requests that the Commission confirm that as a result of registration of the Trust as an open-end management investment company and the redeemable nature of the Shares in Creation Unit size aggregations that, for the reasons previously stated under our request with respect to the exemption under Rule 101(c)(4), transactions in the Shares would be exempted from Rule 102 on the basis of the exception contained in (d)(4) of such Rule. Alternatively, the Trust respectfully requests that the Commission grant an exemption under paragraph (e) of Rule 102 to such effect. Application of Rule 102 in this context would not further the antimanipulative purposes underlying the Rule. The purpose of Rule 102 is to prevent persons from manipulating the price of a security during a distribution and to protect the integrity of the offering process by prohibiting activities that could artificially influence the market for that particular security. For the reasons described in connection with the requested Rule 101 relief, redemption transactions and secondary market transactions in the Shares are not viable means to manipulate the price of a Component Stock during a
distribution of such security. The Trust will redeem the Creation Unit size aggregations of Shares at the net asset value of the Shares. Although the Shares will be traded on the secondary market, the Shares may only be redeemed in Creation Unit size aggregations. Thus, the Trust believes that the NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP redemption by the Trust of the Shares at net asset value in consideration principally for Fund Securities does not involve the abuses that Rule 102 was intended to prevent. Rule lob-10 Rule lob-10 requires a broker or dealer effecting a transaction in a security for a customer to give or send written notification to such customer disclosing the information specified in paragraph (a) of Rule lob-10, including the identity, price and number of shares or units (or principal amount) of the security purchased or sold. The Trust requests that the Commission provide exemptive relief from application of the Rule, as discussed below, with respect to the creation (i.e. issuance) or redemption of Shares (all of which are in Creation Unit size aggregations). The Trust is not requesting exemptive or interpretive relief from Rule lob-10 in connection with purchases and sales of Shares in the secondary market. The Fund proposes that broker-dealers acting for their customers in either depositing Deposit Securities in exchange for Creation Units or redeeming Shares in Creation Unit size aggregations for Fund Securities be permitted to provide such customers with a statement of the number of Creation Units created or redeemed without providing a statement of the identity, number and price of shares of individual Deposit Securities included in the Fund Deposit tendered to the Trust for purposes of creation of Creation Units, or the identity, number and price of shares of Fund Securities to be delivered by the Trust to the redeeming holder. The composition of the Deposit Securities required to be tendered to the Trust through the Custodian for creation purposes and of the Fund Securities to be delivered on redemption will be disseminated by the Custodian on each Business Day and will be applicable to requests for creations or redemption, as the case may be, on that day. This information will be publicly available at the ArnEx and will be made available to requesting broker-dealers or other persons through the NSCC. Moreover, institutions and market professionals will be readily able to calculate independently such information based on publicly available information. We anticipate that any institution or broker-dealer engaging in creation or redemption transactions would have done so only with knowledge of the composition of the applicable Deposit Securities or the Fund Securities to be received on redemption, so that specific information on the Deposit Securities or the Fund Securities to be received on redemption in the Rule 10-10 notification would be redundant. The Trust agrees that any exemptive or interpretive relief under Rule lob-10 with respect to creations and redemptions be subject to the following conditions:
(1) Confirmation statements of creation and redemption transactions in Shares will contain all of the information specified in paragraph (a) of Rule lob-10 other than identity, price, and number of shares of each Component Stock of the Deposit Securities or Fund Securities tendered or received by the customer in the transaction; NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
(2) Any confirmation statement of a creation or redemption transaction in Shares that omits the identity, price, or number of shares of Component Stocks will contain a statement that such omitted information will be provided to the customer upon request; and (3) All such requests will be fulfilled in a timely manner in accordance with paragraph (c) of Rule lob-10. Rule lob-17 Rule lob-17 requires an issuer of a class of publicly traded securities to give notice of certain specified actions (e.g., dividends, stock splits, rights offerings) relating to such class of securities in accordance with Rule lob-17(b). Paragraph (c) of the Rule, however, states that the Rule shall not apply to redeemable securities issued by open-end investment companies and unit investment trusts registered under the 1940 ~ct.'~ Except for the fact that redemption is subject to the minimum condition of tendering 100,000 Shares, the Trust is intended to function like any other open-end fund continuously offering its shares.14 It is in recognition of the foregoing, that the Division of Investment Management issued an order permitting the Trust to issue shares with limited redeemability while still treating the Trust like any other open-end investment company. Therefore, the exemption under paragraph (c) of Rule lob-17, which covers open-end investment companies with fully redeemable shares, should be applicable to the Trust.
Section ll(d)(l): Rule lldl-2
Section 1 l(d)(l) of the Exchange Act generally prohibits a person who is a broker-dealer from
effecting any transaction in which the broker-dealer extends credit to a customer on any security which was part of a new issue in the distribution of which he participated as a member of a selling syndicate or group within thirty days prior to such transaction. Rule 1 ldl-2 provides an exemption from Section 1l(d)(l) for securities issued by a registered open-end investment company or unit investment trust with respect to transactions by a broker-dealer who extends credit on such security, provided the person to whom credit has been extended has owned the security for more than thirty days. The Trust hereby requests clarification that Section 1 l(d)(l) does not apply to broker-dealers that engage in transactions in Shares in the secondary market but do not create Creation Unit size aggregations of shares.'' The Trust believes that application of the thirty-day restriction in Rule 1 ldl-2 to broker-dealers engaging exclusively in secondary market transactions in Shares does 13 See supra note 5. 14 See supra note 2. 15 The request for clarification does not extend to any broker-dealer (including any natural person associated with such broker-dealer) that receives 12b-1 fees from the Fund (each, a "12b-1 brokerdealer"). NYA 741984.7
CLI FFORD CLIFFORD CHANCE US LLP
CHANCE not further the purposes of Section 1 1 (d)(l) or Rule 1 1 dl -2.16 The only compensation a broker-dealer (other than a 12b-1 broker-dealer) will receive for representing a customer in purchasing Shares is the commission charged to that customer, which in all likelihood is the same compensation the brokerdealer would receive in connection with any stock purchase by a customer. There is no special financial incentive to a broker-dealer (other than a 12b-1 broker-dealer), except the broker-dealer's regular commission, to engage in secondary market transactions in Shares, whether as principal or agent. Rule 14e-5 Rule 14e-5 prohibits a person who makes a cash tender offer or exchange offer for any equity security from directly or indirectly purchasing such security (or a security immediately convertible into or exchangeable for such security) otherwise than pursuant to such tender offer or exchange offer. The Rule also applies to the dealer-manager of a tender or exchange offer, its affiliates and to advisers thereto ("Covered Persons"). The Trust respectfully requests that the Commission grant an exemption from Rule 14e-5 to permit any Covered Person (including a member or member organization of the ArnEx or other Market), during the existence of such offer, to (1) redeem Shares in Creation Unit size aggregations for the Fund Securities that may include a security subject to the tender or exchange offer; and (2) engage in secondary market transactions in Shares during such offer. The acquisition of individual Fund Securities by means of redemptions of Shares would be impractical and extremely inefficient in view of the requirement that a minimum of 100,000 Shares be redeemed. In addition, as discussed in the relief requested under Regulation M, application of the Rule's prohibition would impede the valid and useful market and arbitrage activity which would assist secondary market trading and improve Share pricing efficiency. In no case would redemptions of Shares or secondary market transactions by Covered Persons be effected for the purpose of facilitating a tender offer. Accordingly, purchases and redemptions of Shares in the circumstances described would not appear to result in the abuses at which Rule 14e-5 is directed. In addition, the Trust requests that the Staff take a no-action position under Rule 14e-5 if a broker-dealer (including a member or member organization of the AmEx or other Market) acting as a dealer-manager of a tender offer for a Fund Security purchases such securities in the secondary market for the purpose of tendering such securities to purchase one or more Creation Unit Aggregations of Shares, if made in conformance with the following: (i) such bids or purchases are effected in the 16 The Trust also requests that the Division of Market Regulation not recommend any enforcement action to the SEC under Section I l(d)(l) of the Exchange Act if broker-dealers treat Shares, for purposes of Rule lldl-2 under the Exchange
Act, as "securities issued by a registered open-end investment company ... as defined in the Investment Company Act" and thereby extend credit or maintain or arrange for the extension or maintenance of credit on Shares that have been owned by the persons to whom credit is provided for more than 30 days, in reliance on the exemption contained in the Rule. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP ordinary course of business, in connection with a basket of 20 or more securities in which any security that is the subject of a distribution, or any reference security, does not comprise more than 5% of the value of the basket purchased; or (ii) purchases are effected as adjustments to such basket in the ordinary course of business as a result of a change in the composition of the Index; and (iii) such bids or purchases are not effected for the purpose of facilitating such tender offer. Rules 15cl-5 and 15cl-6 Rule 15cl-5 requires a broker or dealer controlled by, controlling, or under common control with, the issuer of a security who induces the purchase or sale by a customer of a security, to disclose the existence of such control before entering into a contract with or for such customer for the purchase or sale of such security. Rule 15cl-6 requires a broker or dealer to send a customer written notification of its participation in the primary or secondary distribution of any security in which it effects any transaction in or for such customer's account or induces the purchase or sale of such security by such customer. For the reasons discussed above, the Trust believes that disclosure by a broker-dealer of a control relationship with the issuer of a Component Stock in the Index, or of a participation in the distribution of one of the Component Stocks, would impose an unnecessary and unjustifiable burden on broker-dealers engaging in Share transactions for their customers. There is no realistic potential for manipulating one of the Component Stock's market price by means of transactions in Shares. Such a strategy would be both expensive and inefficient and, moreover, the Fund will not own more than 10% of any one company's voting securities. Application of the Rules could adversely affect the attractiveness of the Shares to broker-dealers and thereby affect market liquidity and the utility of the Shares as a form of basket trading. The Trust, therefore, requests the Staff to grant no-action relief from application of the rules with respect to creations and redemptions of Shares and secondary market transactions therein. NYA 741984.7
CLIFFORD CLIFFORD CHANCE US LLP
CHANCE
Conclusion
Based on the foregoing, we respectfully request that the Commission and the Staff grant the relief requested herein. The forms of relief requested are similar to those actions that the Commission and the Staff have taken in similar circumstances. If the Commission or the Staff believes that a different format is not appropriate (for example, a no-action position rather than an exemption), we would appreciate the opportunity to revise this request for relief accordingly. Should you have any questions please call me at (212) 878-493 1 or Sheelyn Michael at (212) 878-4985. cc: Brian Bussey Racquel Russell Victoria Crane Norman Reed NYA 741984.7
APPENDIX A
1NI)EX DESCRIPTION
As of September 30,2005, the Lux Nanotech Index component securities had a total market capitalization of approximately $7.5 billion. The average total market capitalization was approximately $214.6 million. The ten largest constituents represented approximately 30.01% of the index weight. The five highest weighted stocks, which represented 23.59% of the index weight, had an average daily trading volume in excess of two million shares during the past two months. All of the component securities traded at least 114,000 shares in each of the previous six months. Lux Nanotech Index as of Se~tember 30,2005 Index Composition Total Index Size (in millions) Concentration Number of Components Percent in Ten Largest Components Size of Companies (in millions) Market Cap. -Median Market Cap. -Arithmetic Average Market Cap. -Smallest Stock Held Market Cap. -Largest Stock Held Market Cap. -$ - Weighted Average Index Characteristics Portfolio PIE Portfolio PIE Excluding Negative Earnings Portfolio PriceIBook Dividend Yield
Top 15 Index Constituents
Name
Altair Nanotechnologies Inc.
Elan Corp Plc - ADR
Flame1 Technologies SA - ADR
Symyx Technologies Inc.
Immunicon CorpIDe
Accelrys Inc.
Biosante Pharmaceuticals Inc.
American Pharmaceutical Partners Inc.
Veeco Instruments Inc.
NVE Corp
Headwaters Inc.
Westaim Corp.
FEI Company
Harris & Harris Group
Nanophase Technologies Corp.
Index Weight
NYA 741984.7
Lux Nanotech Index Constituent Data as of September 30,2005 Average Daily Trading Volume Shares Market Cap Over TwoName Price Outstanding (in millions) Month Period 3M Co $70.55 765.072 $ 53,976 $ 2,951,045 Accelrys Inc $ 6.45 26.127 $ 169 $ 117,431 Air Products & Chemicals Inc $54.10 221.696 $ 11,994 $ 1,109,657 Altair Nanotechnologies Inc $ 2.46 58.919 $ 145 $ 902,096 American Pharmaceutical Partners Inc $45.70 72.208 $ 3,300 Basf Ag -ADR $75.08 537 $ 40,318 Biosante Pharmaceuticals Inc $ 3.15 19.008 $ 60 Cambridge Display Technology $ 6.50 19.485 $ 127 Du Pont (E I) De Nemours $38.52 994.762 $ 38,318 Elan Corp PIC -ADR $ 7.89 426.319 $ 3,364 FEI Company $18.52 33.663 $ 623 Flamel Technologies SA -ADR $17.85 22.702 $ 405 General Electric Co $33.80 10600.8 1 $ 358,307 General Motors Corp $26.42 565.503 $ 14,941 Harris & Harris Group $10.81 17.249 $ 186 Headwaters Inc $33.98 41.565 $ 1,412 Hewlett-Packard Co $27.24 2864.99 $ 78,042 Imrnunicon Corp/De $ 4.25 27.488 $ 117 International Business Machines Corp. $83.19 1595.791 $ 132,754 Nanophase Technologies Corp $ 5.38 17.946 $ 97 NEC Corp -ADR $ 5.60 1995.923 $ 11,177 NVE Corp. $14.45 4.57 $ 66 Skyepharma PIC -ADR $ 7.12 62.9552 $ 448 Symyx Technologies Inc $24.31 32.952 $ 801 Veeco Instruments Inc $15.82 29.94 $ 474 Westaim Corp $ 3.47 92.901 $ 322 Source: AMEX, Factset NYA 741984.7
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
More like this from SEC
SEC published 7 documents in the last 30 days. We email you each new one the day it's published.
Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added · updated